Risk Factors And Clinical Outcomes Of Hospital-Acquired MRSA Infections In Chongqing, China

References

• Jevons MP. “Celbenin” - resistant Staphylococci. Br Med J. 1961;1(5219):113–114. doi:10.1136/bmj.1.5219.124-a14447241
   PubMed Web of Science ®Google Scholar
• Defres S, Marwick C, Nathwani D. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia. Eur Respir J. 2009;34(6):1470–1476. doi:10.1183/09031936.0012230919948913
   PubMed Web of Science ®Google Scholar
• Garcia C, Astocondor L, Reyes J, Carvajal LP, Arias CA, Seas C. Community-associated MRSA infection in remote Amazon basin area, Peru. Emerg Infect Dis. 2016;22(5):921–922. doi:10.3201/eid2205.15188127088661
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–1771. doi:10.1001/jama.298.15.176317940231
   PubMed Web of Science ®Google Scholar
• Lee M, Hesek D, Suvorov M, Lee W, Vakulenko S, Mobashery S. A mechanism-based inhibitor targeting the dd-transpeptidase activity of bacterial penicillin-binding proteins. J Am Chem Soc. 2003;125(52):16322–16326. doi:10.1021/ja038445l14692773
   PubMed Web of Science ®Google Scholar
• Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019;7(2):GPP3-0057–2018. doi:10.1128/microbiolspec.GPP3-0057-2018
   Web of Science ®Google Scholar
• Gould IM, Reilly J, Bunyan D, Walker A. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control. Clin Microbiol Infect. 2010;16(12):1721–1728. doi:10.1111/j.1469-0691.2010.03365.x20825434
   PubMed Web of Science ®Google Scholar
• Claus F, Sachse A, Ried W. On the economic burden of MRSA in Germany. Gesundheitswesen. 2014;76(12):800–806. doi:10.1055/s-0034-138198725372655
   PubMed Web of Science ®Google Scholar
• Hübner C, Hübner NO, Hopert K, Maletzki S, Flessa S. Analysis of MRSA-attributed costs of hospitalized patients in Germany. Eur J Clin Microbiol Infect Dis. 2014;33(10):1817. doi:10.1007/s10096-014-2131-x24838677
   PubMed Web of Science ®Google Scholar
• Ms SE, Youlin C, Qi M, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hospital Epidemiol. 2005;26(2):166–174. doi:10.1086/502522
   Web of Science ®Google Scholar
• Yano K, Minoda Y, Sakawa A, et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics. Acta Orthop. 2009;80(4):486–490. doi:10.3109/1745367090311067519593719
   PubMed Web of Science ®Google Scholar
• Olivo TET, Melo ECD, Rocha C, Fortaleza CMCB. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus among patients from a burn unit in Brazil. Burns. 2009;35(8):1104–1111. doi:10.1016/j.burns.2009.02.00819481351
   PubMed Web of Science ®Google Scholar
• Pujol M, Peña C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1994;13(1):96–102. doi:10.1007/BF20261348168571
   PubMed Web of Science ®Google Scholar
• Cowie SE, Ma IS, Smith RM, Hsiang YN. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc Endovascular Surg. 2005;39(4):327–334. doi:10.1177/15385744050390040416079941
   PubMedGoogle Scholar
• Salangsang JM, Harrison LH, Brooks MM, Shutt KA, Saul MI, Muto CA. Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a Tertiary Care Hospital. Infect Control Hospital Epidemiol. 2010;31(11):1139–1147. doi:10.1086/656595
   Web of Science ®Google Scholar
• Arias-Ortiz PM, Calderon LD, Castillo JS, et al. Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: a multicenter matched case-control study. Biomedica. 2016;36(4):612–619. doi:10.7705/biomedica.v36i4.319327992988
   PubMed Web of Science ®Google Scholar
• Lekkerkerk W, Haenen A, van der Sande M, et al. Newly identified risk factors for MRSA carriage in The Netherlands. PLoS One. 2017;12(11):e188502. doi:10.1371/journal.pone.0188502
   Web of Science ®Google Scholar
• Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol. 2005;26(4):346–351. doi:10.1086/50255015865269
   PubMed Web of Science ®Google Scholar
• Jean B, Mpw P, Eliopoulos GM, Jenkins SG. M100 PerformanceStandards for Antimicrobial Susceptibility Testing. 27th ed. Wayne,Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Horan TCM, Andrus MRBC, Dudeck MAM. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. AJIC. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.002
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Tenover FC, Mcdonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42(3):389–391. doi:10.1086/49936716392087
   PubMed Web of Science ®Google Scholar
• Nguyen DB, Lessa FC, Belflower R, et al. Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. Clin Infect Dis. 2013;57(10):1393–1400. doi:10.1093/cid/cit54623964088
   PubMed Web of Science ®Google Scholar
• Boyce JM. Understanding and controlling methicillin-resistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol. 2002;23(9):485–487. doi:10.1086/50209212269442
   PubMed Web of Science ®Google Scholar
• Boyce JM. Increasing prevalence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol. 1990;11(12):639–642. doi:10.2307/301468662273227
   PubMed Web of Science ®Google Scholar
• Boyce JM. Methicillin-resistant Staphylococcus aureus: a continuing infection control challenge. Eur J Clin Microbiol Infect Dis. 1994;13(1):45–49. doi:10.1007/BF20261268168563
   PubMed Web of Science ®Google Scholar
• Su-Fang G, Jun-Rui W, Yan-Qiu H, et al. Drug resistance and distribution characteristics of Gram-positive bacteria in Western China. Chin J Antibiotics. 2018.
   Google Scholar
• Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002;49(6):999–1005. doi:10.1093/jac/dkf00912039892
   PubMed Web of Science ®Google Scholar
• Marshall C, Wolfe R, Kossmann T, Wesselingh S, Harrington G, Spelman D. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by trauma patients in the intensive care unit. J Hospital Infect. 2004;57(3):245–252. doi:10.1016/j.jhin.2004.03.024
   Web of Science ®Google Scholar
• Washio M. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese elderly care nursing home. Epidemiol Infect. 1997;119(2):285. doi:10.1017/S09502688970077599363030
   PubMed Web of Science ®Google Scholar
• Karas JA, Enoch DA, Emery MM. Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J Hospital Infect. 2006;62(4):480–486. doi:10.1016/j.jhin.2005.10.001
   Web of Science ®Google Scholar
• Sandulescu O, Bleotu C, Matei L, et al. Comparative evaluation of aggressiveness traits in staphylococcal strains from severe infections versus nasopharyngeal carriage. Microb Pathog. 2017;102:45–53. doi:10.1016/j.micpath.2016.11.00627856272
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53–59. doi:10.1086/cid.2003.36.issue-112491202
   PubMed Web of Science ®Google Scholar
• Hassoun A, Linden PK, Friedman B. Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment. Critical Care. 2017;21(1):211. doi:10.1186/s13054-017-1801-328807042
   PubMed Web of Science ®Google Scholar
• Pastagia M, Kleinman LC, Lacerda De La Cruz EG, Jenkins SG. Predicting risk for death from MRSA bacteremia1. Emerg Infect Dis. 2012;18(7):1072–1080. doi:10.3201/eid1807.10137122709685
   PubMed Web of Science ®Google Scholar
• Hanrahan T, Whitehouse T, Lipman J, et al. Vancomycin-associated nephrotoxicity: a meta-analysis of administration by continuous versus intermittent infusion [J]. Int J Antimicrob Agents. 2015;46(3):249–253. doi:10.1016/j.ijantimicag.2015.04.01326141230
   PubMed Web of Science ®Google Scholar
• Harrison CJ. Innate immunity as a key element in host defense against methicillin resistant Staphylococcus aureus [J]. Minerva Pediatr. 2009;61(5):503–514.19794376
   PubMedGoogle Scholar
• Napolitano LM. Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Surg Infect (Larchmt). 2008;9(s1):s17–s27. doi:10.1089/sur.2008.063.supp18844471
   PubMed Web of Science ®Google Scholar